https://doi.org/10.55788/177437a0
According to prior studies, early life exposure is a factor that increases the risk of developing eosinophilic oesophagitis yet the results of most of these studies are limited by recall bias. The current study was conducted to investigate the association between a selected number of perinatal factors with the development of eosinophilic oesophagitis, using registry-based data from the nationwide Denmark cohort [1].
In the large, case-control study presented by Dr Kurt Gencer (Aarhus University, Denmark), 393 cases of neonates with eosinophilic oesophagitis and 3,659 age- and sex-matched controls were included. The researchers collected data prospectively from the Danish health and administrative registries from 1997 to 2019. Dr Gencer and his colleagues defined pregnancy complications, mode of delivery, gestational age at delivery, birth weight, and NICU admission as the perinatal factors and assessed the association between these factors and the development of eosinophilic oesophagitis. They also performed an interaction analysis to see whether the association between the NICU admission and the development of eosinophilic oesophagitis is modified by the preterm status.
In all cases, diagnosis of eosinophilic oesophagitis was confirmed by biopsy and other conditions associated with oesophageal eosinophilia were excluded. The strongest association was observed between the gestational age at delivery and eosinophilic oesophagitis (adjusted OR 3.2; 95% CI 1.6‒6.3) and NICU admission and eosinophilic oesophagitis (adjusted OR 2.4; 95% CI 1.1‒5.5). Moreover, a stronger association was observed between NICU admission and eosinophilic oesophagitis in term (adjusted OR 1.9; 95% CI 1.3‒2.8) than in preterm infants (adjusted OR 0.6; 95% CI 0.3‒1.3).
Therefore, the authors concluded that the association between NICU admission and eosinophilic oesophagitis is independent of the preterm status. Furthermore, pregnancy complications also elevated the risk of eosinophilic oesophagitis (adjusted OR 1.4; 95% CI 1.0‒1.8) whereas weight for gestational age and caesarean delivery didn’t have an influence.
When the gestational age at the delivery was considered, the risk of developing eosinophilic oesophagitis was highest when delivered at the 33rd week of gestation. Regarding the association with the NICU admission, the risk of developing eosinophilic oesophagitis was highest at 2‒3 weeks of NICU admission.
The authors of the study suggest that there is a need for further research to elucidate the underlying pathway of the above associations.
- Kurt G, et al. Perinatal factors and risk of eosinophilic esophagitis - a Nationwide population based case-control study. Poster Su1181, Digestive Disease Week 2022, 21‒24 May, San Diego, CA, USA.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« Dupilumab promising as treatment for eosinophilic oesophagitis Next Article
Cannabis users need more sedation medication for gastroscopy »
« Dupilumab promising as treatment for eosinophilic oesophagitis Next Article
Cannabis users need more sedation medication for gastroscopy »
Table of Contents: DDW 2022
Featured articles
Too much hygiene: CD in later life?
IBD
Antibiotic use elevates IBD risks in senior citizens
Too much hygiene: CD in later life?
Biologic treatment decreases dementia risk in senior IBD patients
CD: Induction treatment with upadacitinib successful in clinical and endoscopic ratings
IL-23 inhibition beneficial in maintenance treatment of UC
Positive outcomes for etrasimod in UC
Colonoscopy in UC: less pain and reduced recurrence with CO2 insufflation
Upper GI
Substantial increase of oesophageal cancer prevalence in the middle-aged
Cannabis users need more sedation medication for gastroscopy
Preterm delivery and NICU admission are associated with the development of eosinophilic oesophagitis
Dupilumab promising as treatment for eosinophilic oesophagitis
Other Highlighted Research
AI-assisted colonoscopy improves adenoma detection
Faecal microbiota transplantation: a safe procedure to treat recurrent Clostridium difficile infections
Oral microbes effective for prevention of recurrent Clostridium difficile infections
Octreotide therapy beats standard of care in GIADs
Improvement in hepatic steatosis but worse lipid profile after alcohol cessation
Normal BMI in NAFLD patients is associated with a higher risk of cardiovascular disease
COVID-19 increases the mortality rates of patients with ALD
Related Articles
November 19, 2021
High COVID-19 mortality in Swiss cancer patients
January 26, 2021
COVID-19 vaccine recommended for all patients with IBD
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com